Fierce Biotech44m
Alphabet's AI biotech Isomorphic Labs hauls in $600M to power next-gen drug design model
AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...
pharmaphorum50m
Alphabet's Isomorphic raises $600m for AI drug discovery
Lilly and Novartis have collectively pledged almost $3 billion to their partnerships with Isomorphic signed last year, which ...
Alphabet-backed Isomorphic Labs bags $600 million funding to build next-gen AI drug design engine
Isomorphic Labs is raising money in its first-ever external funding round from Thrive Capital, a big backer of ChatGPT ...
Alphabet's AI drug unit Isomorphic Labs raises $600 mn from OpenAI backer
Alphabet created Isomorphic Labs in 2021, spinning it out from DeepMind, the AI startup it acquired in 2014. DeepMind’s ...
Alphabet’s AI Drug Unit Raises $600 Million From OpenAI Backer
Isomorphic Labs, the Alphabet Inc.-owned company that uses artificial intelligence to discover drugs, has raised $600 million ...
Alphabet-Backed Isomorphic Labs Raises $600 Million for AI Drug Development
Isomorphic Labs raised $600 million in its first external funding round to boost its artificial-intelligence drug design pipeline across multiple therapeutic areas.
Explore more
Google-backed AI drug discovery startup raises $600 million
Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ever external funding round led by Thrive Capital, the startup said on Monday.
Tariffs Keep Wall Street on Edge
President Trump’s latest trade war threat is expected to come into effect this week, but businesses and investors remain ...
OTS.at3h
Isomorphic Labs announces $600 million funding to further develop its next-generation AI drug design engine and advance therapeutic progra
Isomorphic Labs will utilise the funding to further power its AI drug design engine through frontier AI research and development and to scale and progress its drug candidate ...
Isomorphic Labs, Google’s A.I. Drug Business, Raises $600 Million
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
The Impartial Reporter15h
Ex-footballer Cesc Fabregas and Google DeepMind founder to speak at SXSW London
World Cup-winning former footballer Cesc Fabregas and Google DeepMind co-founder Sir Demis Hassabis have been added to the line-up for the SXSW (South By Southwest) London conference.